Formulation: A lyophilized powder
Formal Name: L-seryl-L-phenylalanylglycyl-L-cysteinyl-L-arginyl-L-phenylalanylglycyl-L-threonyl-L-cysteinyl-L-threonyl-L-valyl-L-glutaminyl-L-lysyl-L-leucyl-L-alanyl-L-histidyl-L-glutaminyl-L-isoleucyl-L-tyrosyl-L-glutaminyl-L-phenylalanyl-L-threonyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-asparaginyl-L-valyl-L-alanyl-L-prolyl-L-arginyl-L-seryl-L-lysyl-L-isoleucyl-L-seryl-L-prolyl-L-glutaminylglycyl-L-tyrosinamide, cyclic (4→9)-disulfide, trifluoroacetate salt
Purity: ≥95%
Formula Markup: C200H308N58O59S2 • XCF3COOH
Formula Weight: 4533,1
Shelf life (days): 1460
Notes: Adrenomedullin (13-52) is a truncated form of adrenomedullin (1-52) (Item No. 24889).{40902} It induces nitric oxide-dependent relaxation of and inhibits release of angiotensin II (Item No. 17150) and endothelin-1 (Item No. 24127) from isolated rat aorta. In vivo, adrenomedullin (13-52) decreases mean arterial pressure (MAP) in spontaneously and renal hypertensive rats in a dose-dependent manner. Adrenomedullin (13-52) (10-3,000 ng per animal) reverses increases in lobar arterial pressure induced by U-46619 (Item No. 16450) in a dose-dependent manner in cats but has no effect on basal lobar arterial pressure or systemic arterial pressure.{39626} It also potentiates inflammatory edema and neutrophil accumulation in rats.{40903}